1,270 Shares in The Clorox Company (NYSE:CLX) Purchased by OneDigital Investment Advisors LLC

OneDigital Investment Advisors LLC bought a new stake in shares of The Clorox Company (NYSE:CLX) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 1,270 shares of the company’s stock, valued at approximately $207,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Innealta Capital LLC acquired a new position in shares of Clorox during the second quarter valued at about $30,000. Trifecta Capital Advisors LLC raised its holdings in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after acquiring an additional 130 shares in the last quarter. Family Firm Inc. bought a new stake in shares of Clorox in the 2nd quarter worth approximately $31,000. Quarry LP lifted its position in shares of Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after acquiring an additional 114 shares during the period. Finally, EntryPoint Capital LLC acquired a new stake in shares of Clorox during the 1st quarter worth approximately $39,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Transactions at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. This trade represents a 11.40 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.57% of the stock is currently owned by corporate insiders.

Clorox Stock Up 0.1 %

Shares of NYSE CLX opened at $169.30 on Friday. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.35. The firm’s 50-day simple moving average is $162.78 and its 200 day simple moving average is $148.48. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The company has a market cap of $20.96 billion, a price-to-earnings ratio of 58.99, a price-to-earnings-growth ratio of 3.13 and a beta of 0.41.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. Clorox’s quarterly revenue was up 27.0% on a year-over-year basis. During the same period in the prior year, the business earned $0.49 earnings per share. On average, research analysts expect that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 2.88%. Clorox’s dividend payout ratio (DPR) is currently 170.04%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. DA Davidson lifted their price target on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and lifted their target price for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. JPMorgan Chase & Co. increased their price target on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. Barclays raised their price target on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research note on Friday, November 1st. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Five analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $155.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.